isocarboxazid has been researched along with Asthma in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GRILLIAT, JP | 1 |
| ANTOINE, F | 1 |
| SAPELIER, P | 1 |
| RASPILLER, A | 1 |
1 other study available for isocarboxazid and Asthma
| Article | Year |
|---|---|
[Notes on the treatment of angina pectoris with a new monoamine oxidase inhibitor (M.A.O.I.)].
Topics: Angina Pectoris; Asthma; Humans; Isocarboxazid; Monoamine Oxidase Inhibitors | 1962 |